ClinConnect ClinConnect Logo
Search / Trial NCT02727517

Early or Late Cord Clamping in the Depressed Neonate

Launched by UPPSALA UNIVERSITY · Mar 29, 2016

Trial Information

Current as of April 25, 2025

Completed

Keywords

Resuscitation Cord Clamping

ClinConnect Summary

At the time of birth, the infant is still attached to the placenta via the umbilical cord. The infant is usually separated from the placenta by clamping the cord with two clamps. Early cord clamping has been generally advised to be carried out in the first 30 seconds after birth, regardless of whether the cord pulsation has ceased. However, arguments against early cord clamping include the reduction in the amount of placental transfusion and any associated benefits of extra blood volume, as delayed clamping allows time for a transfer of the fetal blood in the placenta to the infant at the t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Newborn in need of resuscitation measures (no or irregular breathing despite thorough drying and additional stimulation within one minute after birth)
  • Gestational age ≥ 33 weeks
  • Exclusion Criteria:
  • Monochorionic twins (from an ultrasound scan) or clinical evidence of twin-twin transfusion syndrome, triplets or higher order multiple pregnancy, and fetuses with known congenital malformation

Trial Officials

Ashish KC, MD PhD

Principal Investigator

Uppsala University

Ola Andersson, MD PhD

Principal Investigator

Uppsala University

About Uppsala University

Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.

Locations

Kathmandu, , Nepal

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials